Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C Trzeciak

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Thrombosis Research|July 1, 1981
Comparative plasma heparin levels after subcutaneous administration of calcium and magnesium heparinG Follea, M C Trzeciak, M Dechavanne
Anesthesie, Analgesie, Reanimation|January 1, 1979
[Antiplatelet drugs (author's transl)]M Dechavanne, G Follea, M C Trzeciak
La Nouvelle Presse Medicale|September 18, 1982
[Sodium valproate and changes in hemostasis]C Marchand, M C Trzeciak, G Follea, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1981
[Lupus anticoagulant screening: comparison of 5 tests (author's transl)]G Follea, P Ffrench, M C Trzeciak, et al.
Thrombosis and Haemostasis|January 23, 1991
Dose-response studies of platelet aggregation and bleeding time during eicosapentaenoic acid intakeJ C Bordet, M C Trzeciak, S Durbin, et al.
Annales Francaises D'Anesthesie Et De Reanimation|January 1, 1986
[Isolated increase in the bleeding time: the hemorrhagic risk and therapeutic problems]J Y Ranchère, B Crozet, D Coullioud, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|June 21, 2005
Management of pregnant women with increased risk of venous thrombosisY Dargaud, L Rugeri, J Ninet, et al.
Annales De Dermatologie Et De Venereologie|January 16, 2004
[A necrotic plaque on the thigh]B Roth, S Debarbieux, A-S Causeret, et al.
FEBS Letters|December 6, 1993
The growth-supportive effect of thrombospondin (TSP1) and the expression of TSP1 by human MG-63 osteoblastic cells are both inhibited by dexamethasoneZ Abbadia, J Amiral, M C Trzeciak, et al.
Thrombosis and Haemostasis|July 31, 1998
Monitoring heparin therapy using activated partial thromboplastin time--results of a multicenter trial establishing the therapeutic range for SILIMAT, a reagent with high sensitivity to heparinP Toulon, B Boutière, M H Horellou, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Thrombosis Research|July 1, 1981
Comparative plasma heparin levels after subcutaneous administration of calcium and magnesium heparinG Follea, M C Trzeciak, M Dechavanne
Anesthesie, Analgesie, Reanimation|January 1, 1979
[Antiplatelet drugs (author's transl)]M Dechavanne, G Follea, M C Trzeciak
La Nouvelle Presse Medicale|September 18, 1982
[Sodium valproate and changes in hemostasis]C Marchand, M C Trzeciak, G Follea, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1981
[Lupus anticoagulant screening: comparison of 5 tests (author's transl)]G Follea, P Ffrench, M C Trzeciak, et al.
Thrombosis and Haemostasis|January 23, 1991
Dose-response studies of platelet aggregation and bleeding time during eicosapentaenoic acid intakeJ C Bordet, M C Trzeciak, S Durbin, et al.
Annales Francaises D'Anesthesie Et De Reanimation|January 1, 1986
[Isolated increase in the bleeding time: the hemorrhagic risk and therapeutic problems]J Y Ranchère, B Crozet, D Coullioud, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|June 21, 2005
Management of pregnant women with increased risk of venous thrombosisY Dargaud, L Rugeri, J Ninet, et al.
Annales De Dermatologie Et De Venereologie|January 16, 2004
[A necrotic plaque on the thigh]B Roth, S Debarbieux, A-S Causeret, et al.
FEBS Letters|December 6, 1993
The growth-supportive effect of thrombospondin (TSP1) and the expression of TSP1 by human MG-63 osteoblastic cells are both inhibited by dexamethasoneZ Abbadia, J Amiral, M C Trzeciak, et al.
Thrombosis and Haemostasis|July 31, 1998
Monitoring heparin therapy using activated partial thromboplastin time--results of a multicenter trial establishing the therapeutic range for SILIMAT, a reagent with high sensitivity to heparinP Toulon, B Boutière, M H Horellou, et al.
Pageof 3